ArticleIndian journal of ophthalmology2026
Visual outcomes and patient satisfaction in refractive lens exchange with trifocal intraocular lens in presbyopic hyperopia, emmetropia, and myopia.
Article in Indian journal of ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo compare visual and refractive outcomes and visual function after bilateral refractive lens exchange (RLE) with a trifocal intraocular lens (IOL) in myopic, hyperopic, and emmetropic eyes with presbyopia. STUDY
designRetrospective comparative case series.
methodsCharts of presbyopic patients who underwent RLE with implantation of RayOne Trifocal IOL were retrospectively reviewed. Visual and refractive outcomes were evaluated at 3 months. Patient satisfaction, spectacle independence, and visual disturbance were assessed by patient reported outcomes measures (PROMs) questionnaires.
resultsA total of 6788 eyes were classified into refractive groups. Mean (± standard deviation) visual acuity (logMAR) at 3 months: Group A (emmetropic), binocular uncorrected distance visual acuity (UDVA), 0.01 ± 0.11; monocular corrected distance visual acuity (CDVA), 0.01 ± 0.03; binocular uncorrected near visual acuity (UNVA) at 40 cm, 0.08 ± 0.07; binocular uncorrected intermediate visual acuity (UIVA) at 66 cm, 0.12 ± 0.11; postoperative spherical equivalent (SE) (diopters (D)), -0.05 ± 0.29. Group B (myopic), binocular UDVA, 0.03 ± 0.23; monocular CDVA, 0.01 ± 0.02; binocular UNVA, 0.07 ± 0.07; binocular UIVA, 0.12 ± 0.08; SE, -0.05 ± 0.52. Group C (hyperopic), binocular UDVA, 0.00 ± 0.03; monocular CDVA, 0.01 ± 0.02; binocular UNVA, 0.08 ± 0.07; binocular UIVA, 0.21 ± 0.09; SE, -0.08 ± 0.30. PROMs showed high levels of satisfaction and spectacle independence at all distances with worse results in myopes. Night vision was worse in hyperopes.
conclusionsIn this retrospective analysis, RayOne Trifocal provided good visual performance at all distances, resulting in excellent levels of spectacle independence and satisfaction despite the preoperative refraction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.